In our results, the frequency of MYD88L265P, PIM1, and CD79B mutations and CDKN2A/B loss was significantly higher in both PCNSL and PTL than in DLBCL NOS and PMLBL, which was consistent with previous studies.19, 34, 35. The gene discussed is CD79B; the disease is primary central nervous system lymphoma.